Literature DB >> 25014884

Tissue-nonspecific alkaline phosphatase deficiency causes abnormal craniofacial bone development in the Alpl(-/-) mouse model of infantile hypophosphatasia.

Jin Liu1, Hwa Kyung Nam1, Cassie Campbell1, Kellen Cristina da Silva Gasque2, José Luis Millán2, Nan E Hatch3.   

Abstract

UNLABELLED: Tissue-nonspecific alkaline phosphatase (TNAP) is an enzyme present on the surface of mineralizing cells and their derived matrix vesicles that promotes hydroxyapatite crystal growth. Hypophosphatasia (HPP) is an inborn-error-of-metabolism that, dependent upon age of onset, features rickets or osteomalacia due to loss-of function mutations in the gene (Alpl) encoding TNAP. Craniosynostosis is prevalent in infants with HPP and other forms of rachitic disease but how craniosynostosis develops in these disorders is unknown.
OBJECTIVES: Because craniosynostosis carries high morbidity, we are investigating craniofacial skeletal abnormalities in Alpl(-/-) mice to establish these mice as a model of HPP-associated craniosynostosis and determine mechanisms by which TNAP influences craniofacial skeletal development.
METHODS: Cranial bone, cranial suture and cranial base abnormalities were analyzed by micro-CT and histology. Craniofacial shape abnormalities were quantified using digital calipers. TNAP expression was suppressed in MC3T3E1(C4) calvarial cells by TNAP-specific shRNA. Cells were analyzed for changes in mineralization, gene expression, proliferation, apoptosis, matrix deposition and cell adhesion.
RESULTS: Alpl(-/-) mice feature craniofacial shape abnormalities suggestive of limited anterior-posterior growth. Craniosynostosis in the form of bony coronal suture fusion is present by three weeks after birth. Alpl(-/-) mice also exhibit marked histologic abnormalities of calvarial bones and the cranial base involving growth plates, cortical and trabecular bone within two weeks of birth. Analysis of calvarial cells in which TNAP expression was suppressed by shRNA indicates that TNAP deficiency promotes aberrant osteoblastic gene expression, diminished matrix deposition, diminished proliferation, increased apoptosis and increased cell adhesion.
CONCLUSIONS: These findings demonstrate that Alpl(-/-) mice exhibit a craniofacial skeletal phenotype similar to that seen in infants with HPP, including true bony craniosynostosis in the context of severely diminished bone mineralization. Future studies will be required to determine if TNAP deficiency and other forms of rickets promote craniosynostosis directly through abnormal calvarial cell behavior, or indirectly due to deficient growth of the cranial base.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Animal models; Bone; Craniofacial; Disorders of phosphate; Micro-CT (μCT)

Mesh:

Substances:

Year:  2014        PMID: 25014884      PMCID: PMC4149826          DOI: 10.1016/j.bone.2014.06.040

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  64 in total

1.  Functional characterization of osteoblasts and osteoclasts from alkaline phosphatase knockout mice.

Authors:  C Wennberg; L Hessle; P Lundberg; S Mauro; S Narisawa; U H Lerner; J L Millán
Journal:  J Bone Miner Res       Date:  2000-10       Impact factor: 6.741

Review 2.  Management of craniosynostoses.

Authors:  D Renier; E Lajeunie; E Arnaud; D Marchac
Journal:  Childs Nerv Syst       Date:  2000-11       Impact factor: 1.475

3.  Tooth root dentin mineralization defects in a mouse model of hypophosphatasia.

Authors:  B L Foster; K J Nagatomo; H W Tso; A B Tran; F H Nociti; S Narisawa; M C Yadav; M D McKee; J I Millán; M J Somerman
Journal:  J Bone Miner Res       Date:  2013-02       Impact factor: 6.741

4.  Osteoblast tissue-nonspecific alkaline phosphatase antagonizes and regulates PC-1.

Authors:  K A Johnson; L Hessle; S Vaingankar; C Wennberg; S Mauro; S Narisawa; J W Goding; K Sano; J L Millan; R Terkeltaub
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2000-10       Impact factor: 3.619

5.  Age at initial consultation for craniosynostosis: comparison across different patient characteristics.

Authors:  Mitchel Seruya; Albert K Oh; Michael J Boyajian; John S Myseros; Amanda L Yaun; Robert F Keating; Gary F Rogers
Journal:  J Craniofac Surg       Date:  2013-01       Impact factor: 1.046

6.  Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization.

Authors:  Lovisa Hessle; Kristen A Johnson; H Clarke Anderson; Sonoko Narisawa; Adnan Sali; James W Goding; Robert Terkeltaub; José Luis Millan
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-24       Impact factor: 11.205

7.  Progressive postnatal craniosynostosis and increased intracranial pressure.

Authors:  John P Connolly; Joseph Gruss; Marianne L Seto; Michael F Whelan; Richard Ellenbogen; Avery Weiss; Steven R Buchman; Michael L Cunningham
Journal:  Plast Reconstr Surg       Date:  2004-04-15       Impact factor: 4.730

8.  Concerted regulation of inorganic pyrophosphate and osteopontin by akp2, enpp1, and ank: an integrated model of the pathogenesis of mineralization disorders.

Authors:  Dympna Harmey; Lovisa Hessle; Sonoko Narisawa; Kristen A Johnson; Robert Terkeltaub; José Luis Millán
Journal:  Am J Pathol       Date:  2004-04       Impact factor: 4.307

Review 9.  The role of phosphatases in the initiation of skeletal mineralization.

Authors:  José Luis Millán
Journal:  Calcif Tissue Int       Date:  2012-11-27       Impact factor: 4.333

10.  In vivo overexpression of tissue-nonspecific alkaline phosphatase increases skeletal mineralization and affects the phosphorylation status of osteopontin.

Authors:  Sonoko Narisawa; Manisha C Yadav; José Luis Millán
Journal:  J Bone Miner Res       Date:  2013-07       Impact factor: 6.741

View more
  38 in total

1.  FAK Promotes Osteoblast Progenitor Cell Proliferation and Differentiation by Enhancing Wnt Signaling.

Authors:  Chunhui Sun; Hebao Yuan; Li Wang; Xiaoxi Wei; Linford Williams; Paul H Krebsbach; Jun-Lin Guan; Fei Liu
Journal:  J Bone Miner Res       Date:  2016-10-24       Impact factor: 6.741

2.  Dental and craniofacial defects in the Crtap-/- mouse model of osteogenesis imperfecta type VII.

Authors:  He Xu; Sydney A Lenhart; Emily Y Chu; Michael B Chavez; Helen F Wimer; Milena Dimori; Martha J Somerman; Roy Morello; Brian L Foster; Nan E Hatch
Journal:  Dev Dyn       Date:  2020-03-12       Impact factor: 3.780

3.  Mineralization defects in cementum and craniofacial bone from loss of bone sialoprotein.

Authors:  B L Foster; M Ao; C Willoughby; Y Soenjaya; E Holm; L Lukashova; A B Tran; H F Wimer; P M Zerfas; F H Nociti; K R Kantovitz; B D Quan; E D Sone; H A Goldberg; M J Somerman
Journal:  Bone       Date:  2015-05-09       Impact factor: 4.398

4.  Fibromodulin reprogrammed cells: A novel cell source for bone regeneration.

Authors:  Chen-Shuang Li; Pu Yang; Kang Ting; Tara Aghaloo; Soonchul Lee; Yulong Zhang; Kambiz Khalilinejad; Maxwell C Murphy; Hsin Chuan Pan; Xinli Zhang; Benjamin Wu; Yan-Heng Zhou; Zhihe Zhao; Zhong Zheng; Chia Soo
Journal:  Biomaterials       Date:  2016-01-07       Impact factor: 12.479

5.  Tissue nonspecific alkaline phosphatase promotes calvarial progenitor cell cycle progression and cytokinesis via Erk1,2.

Authors:  Hwa Kyung Nam; Iva Vesela; Erica Siismets; Nan E Hatch
Journal:  Bone       Date:  2018-10-17       Impact factor: 4.398

Review 6.  Ultrastructure and biological function of matrix vesicles in bone mineralization.

Authors:  Tomoka Hasegawa
Journal:  Histochem Cell Biol       Date:  2018-02-06       Impact factor: 4.304

7.  Tissue-nonspecific alkaline phosphatase is an anti-inflammatory nucleotidase.

Authors:  L Bessueille; A Briolay; J Como; S Mebarek; C Mansouri; M Gleizes; A El Jamal; R Buchet; C Dumontet; E L Matera; E Mornet; J L Millan; C Fonta; D Magne
Journal:  Bone       Date:  2020-02-04       Impact factor: 4.398

Review 8.  Alkaline Phosphatase Replacement Therapy for Hypophosphatasia in Development and Practice.

Authors:  S A Bowden; B L Foster
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

9.  Enzyme replacement for craniofacial skeletal defects and craniosynostosis in murine hypophosphatasia.

Authors:  Jin Liu; Cassie Campbell; Hwa Kyung Nam; Alexandre Caron; Manisha C Yadav; José Luis Millán; Nan E Hatch
Journal:  Bone       Date:  2015-05-08       Impact factor: 4.398

10.  Redox-Dependent Bone Alkaline Phosphatase Dysfunction Drives Part of the Complex Bone Phenotype in Mice Deficient for Memo1.

Authors:  Matthias B Moor; Suresh K Ramakrishnan; Finola Legrand; Silvia Dolder; Mark Siegrist; Fanny Durussel; Gabriel Centeno; Dmitri Firsov; Nancy E Hynes; Willy Hofstetter; Olivier Bonny
Journal:  JBMR Plus       Date:  2018-01-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.